Topic: Skeletal muscle anabolism is a side effect of therapy with the MEK inh

Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.

http://www.nature.com/bjc/journal/vaop/ … 2144a.html

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.